Vulnerability of desensitized or curare-treated acetylcholine receptors to irreversible blockade by cobra toxin.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000818:Animals; D000992:Antitoxins / Q000494:pharmacology; D001001:Anura; D002118:Calcium / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D003472:Curare / Q000494:pharmacology*; D004594:Electrophysiology; D066298:In Vitro Techniques; D007478:Iontophoresis; D007700:Kinetics; D008433:Mathematics; D008564:Membrane Potentials / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology; D010455:Peptides / Q000494:pharmacology; D011950:Receptors, Cholinergic; D011955:Receptors, Drug / Q000187:drug effects*; D012911:Snakes; D014118:Toxins, Biological / Q000008:administration & dosage / Q000494:pharmacology*; D014403:Tubocurarine / Q000494:pharmacology; D014688:Venoms
D000992:Antitoxins; D010455:Peptides; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D014118:Toxins, Biological; D014688:Venoms; D003472:Curare; D002217:Carbachol; D000109:Acetylcholine; D002118:Calcium; D014403:Tubocurarine